Their ability to lower C-reactive protein (CRP) provides a biomarker-based link between statin exposure and anti-inflammatory benefit, suggesting mechanisms that could explain mortality and cognitive protection across diverse stroke subtypes. This evidence concerns the gene CRP and stroke disorder.